Related Experiment Video
Updated: Jul 24, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Non-nicotine pharmacotherapy for smoking cessation
1Department of Preventive Medicine and Family Medicine, Loma Linda University Schools of Medicine and Public Health, Loma Linda, California 92350, USA. lhferry@aol.com
Primary Care
|August 7, 1999
Summary
Discover non-nicotine smoking cessation treatments. This review covers bupropion and other unapproved medications, exploring their neurobiology and effectiveness for nicotine dependence.
Area of Science:
- Pharmacology
- Neuroscience
- Addiction Medicine
Background:
- Nicotine addiction is a complex neurobiological condition.
- Effective smoking cessation requires treatments addressing addiction's neurobiology and co-occurring conditions.
- Non-nicotine treatments offer alternatives for smokers seeking to quit.
Purpose of the Study:
- To review non-nicotine pharmacotherapies for nicotine dependence.
- To explore mechanisms of action and clinical trial effectiveness of various treatments.
- To discuss the selection criteria for non-nicotine smoking cessation aids.
Main Methods:
- Literature review of non-nicotine treatments for nicotine dependence.
- Analysis of pharmacologic and neurobiological mechanisms.
- Evaluation of clinical trial data for unapproved medications.
Main Results:
- Bupropion is the only FDA-approved non-nicotine medication, targeting dopaminergic and noradrenergic systems.
- Various other unapproved medications are under investigation for smoking cessation.
- Effectiveness varies among different non-nicotine approaches.
Conclusions:
- Non-nicotine treatments are crucial for comprehensive nicotine dependence management.
- Further research is needed to establish the efficacy of unapproved medications.
- Treatment selection should consider patient acceptability and co-morbidities.
Related Concept Videos
01:17Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:26Pharmaceutical Poisoning: Treatment Strategies
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...